| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION
Department of Pharmacological and Physiological Science, Saint Louis University, St. Louis, Missouri
Submitted 3 November 2004 ; accepted in final form 25 November 2004
Intermedin (IMD)/adrenomedullin-2 (AM2) is a novel peptide that was independently discovered by two groups. The 47-amino acid peptide is homologous to adrenomedullin (AM) and can activate both the AM and calcitonin gene-related peptide (CGRP) receptors. IMD should therefore have actions similar to those of AM and CGRP. Indeed, like AM and CGRP, intravenous administration of IMD decreased blood pressure in rats and mice. We demonstrate here that immunoreactive IMD is present in plasma as well as heart, lung, stomach, kidney, pituitary, and brain. Because IMD is present in brain and both AM and CGRP have potent central nervous system (CNS) effects, we examined the ability of IMD within brain to regulate blood pressure and ingestive behaviors. Administration of IMD into the lateral cerebroventricle of rats caused significant, long-lasting elevations in mean arterial pressure and heart rate. These elevations are similar to the effects of CGRP and significantly greater than the effects of AM. IMD-induced elevations in mean arterial pressure were inhibited by intravenous administration of phentolamine, indicating that IMD activates the sympathetic nervous system. Intracerebroventricular administration of IMD also inhibited food and water intake in sated and in food- and water-restricted animals. The effects on feeding are likely related to activation of the CGRP receptor and are independent of the effects on water intake, which are likely through the AM receptor. Our data indicate that IMD has potent actions within the CNS that may be a result of the combined activation of both AM and CGRP receptors.
calcitonin gene-related peptide; heart rate; brain
This article has been cited by other articles:
|
|
 |
|
  U. Pfeil, M. Aslam, R. Paddenberg, K. Quanz, C. L. Chang, J.-I. Park, B. Gries, A. Rafiq, P. Faulhammer, A. Goldenberg, et al. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L837 - L845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grossini, C. Molinari, D. A. S. G. Mary, F. Uberti, P. P. Caimmi, and G. Vacca Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and {beta}-adrenoreceptor-mediated nitric oxide release J Appl Physiol, October 1, 2009; 107(4): 1037 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chauhan, U. Yallampalli, Y.-L. Dong, G. D.V. Hankins, and C. Yallampalli Expression of Adrenomedullin 2 (ADM2)/Intermedin (IMD) in Human Placenta: Role in Trophoblast Invasion and Migration Biol Reprod, October 1, 2009; 81(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. C. Yosten and W. K. Samson Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R330 - R336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ogoshi, S. Nobata, and Y. Takei Potent osmoregulatory actions of homologous adrenomedullins administered peripherally and centrally in eels Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2075 - R2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Samson, J. V. Zhang, O. Avsian-Kretchmer, K. Cui, G. L. C. Yosten, C. Klein, R.-M. Lyu, Y. X. Wang, X. Q. Chen, J. Yang, et al. Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions J. Biol. Chem., November 14, 2008; 283(46): 31949 - 31959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Samson, M. M. White, C. Price, and A. V. Ferguson Obestatin acts in brain to inhibit thirst Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R637 - R643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chauhan, U. Yallampalli, L. Reed, and C. Yallampalli Adrenomedullin 2 Antagonist Infusion to Rats During Midgestation Causes Fetoplacental Growth Restriction Through Apoptosis Biol Reprod, December 1, 2006; 75(6): 940 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dong, M. M. Taylor, W. K. Samson, and J. Ren Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes J Appl Physiol, September 1, 2006; 101(3): 778 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujisawa, Y. Nagai, A. Miyatake, K. Miura, T. Shokoji, A. Nishiyama, S. Kimura, and Y. Abe Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1120 - H1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hashimoto, S. Hyodo, M. Kawasaki, T. Mera, L. Chen, A. Soya, T. Saito, H. Fujihara, T. Higuchi, Y. Takei, et al. Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E753 - E761. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
